Verastem | VSTM - Gross Profit On Sales


Verastem reported $545K in Gross Profit on Sales for its fiscal quarter ending in December of 2021.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
AstraZeneca USD 12.39B 5M Dec/2025
Curis USD -7.72M 140K Jun/2024
Cytokinetics USD 17.76M 15.82M Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Incyte USD 1.39B 118.68M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
TG Therapeutics USD 154.43M 20.81M Dec/2025
Verastem USD 545K 543K Dec/2021